| Literature DB >> 36193093 |
Fang Cao1, Zhaoheng Liu2, Qingxun Hao3, Ronghua Zhao4, Lei Bao4, Xiaolan Cui4, Yang Jiao1.
Abstract
Coronavirus disease 2019 (COVID-19), which causes severe respiratory illness, was first reported in Wuhan, China. The etiology of the disease is a new novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was reported to share the same origin as SARS-CoV, causing severe public health events in 2002. Unlike the SARS-CoV, which was conquered in the early summer of 2003, this virus was still contagious widely and reached a pandemic level. It can still spread fast even if the season's temperature is raised. Here, we made a model of pneumonia of human coronavirus 229E (HCoV-229E) with damp-heat syndrome treated by Xiangqin Kanggan granules to find a new medicine for treating these kinds of infectious diseases coronaviruses induced.Entities:
Year: 2022 PMID: 36193093 PMCID: PMC9525736 DOI: 10.1155/2022/7609550
Source DB: PubMed Journal: Can J Infect Dis Med Microbiol ISSN: 1712-9532 Impact factor: 2.585
Comparison of the lung index in groups.
| Group | Dose(g/kg/d) | Quantities | Lung index | Lung index inhibition rate | |
|---|---|---|---|---|---|
| (Lungs weight | % | ||||
| Sham | — | 10 | 0.70 ± 0.08 | — | |
| Damp-heat | — | 10 | 0.73 ± 0.06 | — | |
| 229E | — | 10 | 0.96 ± 0.13## | — | |
| Model | — | 10 | 0.94 ± 0.07## | — | |
| Chloroquine phosphate | 0.09 | 10 | 0.85 ± 0.14 | 34.63 | |
| XQKGG | High | — | 10 | 0.89 ± 0.06 | 20.66 |
| Middle | — | 10 | 0.87 ± 0.09 | 26.50 | |
| Low | 10 | 0.85 ± 0.09 | 34.90 | ||
Compared with the sham group, ##p < 0.01; compared with the model group, p < 0.05.
Figure 1Effect of XQKGG on HCoV-229E induced pulmonary histopathology in mice. Pulmonary structure and tissue of bronchiole and pulmonary interstitial inflammatory infiltration in each group. There was less inflammation and structure destroyed in XQKGG groups.
Comparison of the levels of virus in lung tissue in groups (n = 6).
| Group | Level of 225E nucleic acid (copies/ml) | |
|---|---|---|
| Sham | 0 | |
| Damp-heat | 0 | |
| 229E | 12336.04 ± 3262.06## | |
| Model | 16449.05 ± 5725.45## | |
| Chloroquine phosphate | 6590.84 ± 2196.45 | |
| XQKGG | High | 34835.12 ± 49849.39 |
| Middle | 8519.02 ± 2031.83 | |
| Low | 6173.94 ± 2220.10 | |
Compared with the sham group, ##p < 0.01; compared with the model group, P < 0.05, P < 0.01.
Comparison of the percentages of immune cells in the blood in groups (n = 6).
| Group | Dose (g/kg/d) | Percentages of B cells (%) | |
|---|---|---|---|
| Sham | — | 25.33 ± 5.09 | |
| Damp-heat | — | 20.57 ± 4.06 | |
| 229E | — | 16.64 ± 7.21# | |
| Model | — | 28.09 ± 4.37 | |
| Chloroquine phosphate | 0.09 | 15.05 ± 4.83 | |
| XQKGG | High | — | 12.33 ± 6.48 |
| Middle | — | 19.71 ± 6.47 | |
| Low | — | 21.86 ± 6.32 | |
Compared with the sham group, ##p < 0.01#p < 0.05; compared with the model group, P < 0.05, P < 0.01.
Comparison of cytokines in hypothalamus tissue of mice in groups (n = 6).
| Group | Dose (g/kg/d) | Levels of cytokines (ng/ml) | ||
|---|---|---|---|---|
| PGE2 | CAMP | |||
| Sham | — | 554.72 ± 49.06 | 7121.33 ± 718.93 | |
| Damp-heat | — | 571.39 ± 93.63 | 6368.00 ± 800.87 | |
| 229E | — | 642.50 ± 41.12## | 13431.33 ± 1096.44## | |
| Model | — | 654.72 ± 110.48 | 11988.00 ± 1283.92## | |
| Chloroquine phosphate | 0.09 | 628.33 ± 75.15 | 10088.00 ± 484.77 | |
| XQKGG | High | — | 757.78 ± 57.76 | 10324.67 ± 841.68 |
| Middle | — | 690.28 ± 64.79 | 9631.33 ± 507.96 | |
| Low | — | 748.33 ± 108.18 | 9711.33 ± 713.83 | |
Compared with the sham group, ##p < 0.01; compared with the model group, P < 0.05, P < 0.01.
Figure 2Comparison of the cytokines of IL-1β (a), CD14 (b), MDA (c), and SOD (d) in rat lung tissue with the method of ELISA. Comparison between the sham group and the 229E group with a level of IL-1β (P < 0.01), CD14 (P < 0.05), MDA (P < 0.01), and SOD (P < 0.01); comparison between the sham group and the model group with a level of IL-1β (P < 0.01), CD14 (P < 0.01), MDA (P < 0.01), and SOD (P < 0.01); comparison between the model group and the chloroquine phosphate group/high and middle doses of XQKGG groups with the level of IL-1β (P < 0.01), CD14 (P < 0.01), MDA (P < 0.01), and SOD (P < 0.01); comparison between the model group and a low dose of XQKGG group with a level of IL-1β (P < 0.05), CD14 (P < 0.01), MDA (P < 0.05), and SOD (P < 0.01).